(Q69223427)
Statements
Dose-related prolactin inhibitory effect of the new long-acting dopamine receptor agonist cabergoline in normal cycling, puerperal, and hyperprolactinemic women (English)
G B Melis
M Gambacciani
A M Paoletti
V Mais
P Baroldi
1 September 1987